We are live on ! Find out more
INZY

Inozyme Pharma

Delisted

INZY was delisted on the 30th of June, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$14.3M -$1.95M -513,629 -9%
PBPIA
2
Pivotal bioVenture Partners Investment Advisor
California
$12.5M
SI
3
Sofinnova Investments
California
$11.9M
AAA
4
Affinity Asset Advisors
New York
$11M +$4.37M +1,150,000 +41%
RSCM
5
Rock Springs Capital Management
Maryland
$10.7M +$225K +59,100 +2%
BlackRock
6
BlackRock
New York
$10.6M +$1.22M +321,303 +9%
Vanguard Group
7
Vanguard Group
Pennsylvania
$7.29M +$33.9K +8,911 +0.3%
NMC
8
NEA Management Company
Maryland
$6.75M
EAM
9
Eventide Asset Management
Massachusetts
$6.15M -$7.28M -1,914,436 -46%
Millennium Management
10
Millennium Management
New York
$5.21M +$524K +137,821 +8%
Fidelity Investments
11
Fidelity Investments
Massachusetts
$5.05M -$2.49M -654,231 -26%
SB
12
Samsara BioCapital
California
$4.33M
SVCM
13
Saturn V Capital Management
Texas
$3.81M +$22K +5,772 +0.4%
SFM
14
Sphera Funds Management
Israel
$3.3M
Geode Capital Management
15
Geode Capital Management
Massachusetts
$3.27M +$32.1K +8,450 +0.7%
BOCH
16
Blue Owl Capital Holdings
New York
$2.99M -$152K -40,000 -4%
State Street
17
State Street
Massachusetts
$2.79M -$163K -42,965 -4%
WP
18
Woodline Partners
California
$2.78M
DMKJ
19
David M. Knott Jr
$1.93M +$496K +130,451 +23%
Citadel Advisors
20
Citadel Advisors
Florida
$1.71M +$2.16M +567,349 +1,145%
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$1.4M +$223K +58,518 +13%
Northern Trust
22
Northern Trust
Illinois
$1.25M +$45.3K +11,919 +3%
S
23
Sanofi
France
$1.23M +$1.69M +443,255 New
Renaissance Technologies
24
Renaissance Technologies
New York
$1.17M +$976K +256,599 +156%
Goldman Sachs
25
Goldman Sachs
New York
$700K -$740K -194,595 -44%